1
|
Hellwig S, Grittner U, Elgeti M, Wyschkon S, Nagel SN, Fiebach JB, Krause T, Herm J, Scheitz JF, Endres M, Nolte CH, Haeusler KG, Elgeti T. Evaluation of left ventricular function in patients with acute ischaemic stroke using cine cardiovascular magnetic resonance imaging. ESC Heart Fail 2020; 7:2572-2580. [PMID: 32667736 PMCID: PMC7524103 DOI: 10.1002/ehf2.12833] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2020] [Revised: 05/05/2020] [Accepted: 05/27/2020] [Indexed: 01/09/2023] Open
Abstract
AIMS Heart failure (HF) is frequent in patients with acute ischaemic stroke (AIS) and associated with higher morbidity and mortality. Assessment of cardiac function in AIS patients using cardiovascular MRI (CMR) may help to detect HF. We report the rate of systolic and diastolic dysfunction in a cohort of patients with AIS using CMR and compare cine real-time (CRT) sequences with the reference of segmented cine steady-state free precession sequences. METHODS AND RESULTS Patients with AIS without known atrial fibrillation were prospectively enrolled in the HEart and BRain Interfaces in Acute Ischemic Stroke (HEBRAS) study (NCT02142413) and underwent CMR at 3 Tesla within 7 days after AIS. Validity of CRT sequences was determined in 50 patients. A total of 229 patients were included in the analysis (mean age 66 years; 35% women; HF 2%). Evaluation of cardiac function was successful in 172 (75%) patients. Median time from stroke onset to CMR was 82 h (interquartile range 56-111) and 54 h (interquartile range 31-78) from cerebral MRI to CMR. Systolic dysfunction was observed in 43 (25%) and diastolic dysfunction in 102 (59%) patients. Diagnostic yield was similar using CRT or segmented cine imaging (no significant difference in left ventricular ejection fraction, myocardial mass, time to peak filling rate, and peak filling rate ratio E/A). Intraobserver and interobserver agreement was high (κ = 0.78-1.0 for all modalities). CONCLUSIONS Cardiovascular MRI at 3 Tesla is an appropriate method for the evaluation of cardiac function in a selected cohort of patients with AIS. Systolic and diastolic dysfunction is frequent in these patients. CRT imaging allows reliable assessment of systolic and diastolic function.
Collapse
Affiliation(s)
- Simon Hellwig
- Department of NeurologyCharité—Universitätsmedizin BerlinBerlinGermany
- Centre for Stroke Research BerlinCharité—Universitätsmedizin BerlinBerlinGermany
| | - Ulrike Grittner
- Institute of Biometry and Clinical EpidemiologyCharité—Universitätsmedizin BerlinBerlinGermany
- Berlin Institute of HealthBerlinGermany
| | - Matthias Elgeti
- Jules Stein Eye Institute and Department for Chemistry and BiochemistryUniversity of CaliforniaLos AngelesCAUSA
| | | | | | - Jochen B. Fiebach
- Centre for Stroke Research BerlinCharité—Universitätsmedizin BerlinBerlinGermany
| | - Thomas Krause
- Department of NeurologyJüdisches Krankenhaus BerlinBerlinGermany
| | - Juliane Herm
- Department of NeurologyCharité—Universitätsmedizin BerlinBerlinGermany
- Centre for Stroke Research BerlinCharité—Universitätsmedizin BerlinBerlinGermany
| | - Jan F. Scheitz
- Department of NeurologyCharité—Universitätsmedizin BerlinBerlinGermany
- Centre for Stroke Research BerlinCharité—Universitätsmedizin BerlinBerlinGermany
- Berlin Institute of HealthBerlinGermany
- German Centre for Cardiovascular Diseases (DZHK), partner site BerlinBerlinGermany
| | - Matthias Endres
- Department of NeurologyCharité—Universitätsmedizin BerlinBerlinGermany
- Centre for Stroke Research BerlinCharité—Universitätsmedizin BerlinBerlinGermany
- Berlin Institute of HealthBerlinGermany
- German Centre for Neurodegenerative Diseases (DZNE), partner site BerlinBerlinGermany
- German Centre for Cardiovascular Diseases (DZHK), partner site BerlinBerlinGermany
| | - Christian H. Nolte
- Department of NeurologyCharité—Universitätsmedizin BerlinBerlinGermany
- Centre for Stroke Research BerlinCharité—Universitätsmedizin BerlinBerlinGermany
- Berlin Institute of HealthBerlinGermany
- German Centre for Neurodegenerative Diseases (DZNE), partner site BerlinBerlinGermany
- German Centre for Cardiovascular Diseases (DZHK), partner site BerlinBerlinGermany
| | | | - Thomas Elgeti
- Department of RadiologyCharité—Universitätsmedizin BerlinBerlinGermany
| |
Collapse
|
2
|
Anker MS, Bouleti C, Christodoulides T, Durante A, Gara E, Hadzibegovic S, Keramida K, Lena A, Massouh A, Milinkovic I, Nägele MP, Nossikoff A, Plácido R, Radovits T, Tolppanen H, Vergaro G, Wallner M, Welch S, Lopatin Y, Lainscak M, Mebazaa A, Coats AJS, Seferović PM, Jankowska EA. The heart failure specialists of tomorrow: a network for young cardiovascular scientists and clinicians. ESC Heart Fail 2020; 7:873-877. [PMID: 32352242 PMCID: PMC7261537 DOI: 10.1002/ehf2.12674] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2020] [Indexed: 12/29/2022] Open
Abstract
The “Heart failure specialists of Tomorrow” (HoT) group gathers young researchers, physicians, basic scientists, nurses and many other professions under the auspices of the Heart Failure Association of the European Society of Cardiology. After its foundation in 2014, it has quickly grown to a large group of currently 925 members. Membership in this growing community offers many advantages during, before, and after the ‘Heart Failure and World Congress on Acute Heart Failure’. These include: eligibility to receive travel grants, participation in moderated poster sessions and young researcher and clinical case sessions, the HoT walk, the career café, access to the networking opportunities, and interaction with a large and cohesive international community that constantly seeks multinational collaborations.
Collapse
Affiliation(s)
- Markus S Anker
- Division of Cardiology and Metabolism, Department of Cardiology (CVK), Charité, Berlin, Germany.,Department of Cardiology (CBF), Charité, Berlin, Germany.,Berlin Institute of Health Center for Regenerative Therapies (BCRT), Berlin, Germany.,DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany
| | - Claire Bouleti
- University of Poitiers, Clinical Investigation Center (CIC) INSERM 1402, Cardiology Department, Poitiers University Hospital, Poitiers, France
| | | | - Angela Durante
- Biomedicine and Prevention Department, University of Rome "Tor Vergata", Rome, Italy
| | - Edit Gara
- Heart and Vascular Center, Semmelweis University, Budapest, Hungary
| | - Sara Hadzibegovic
- Division of Cardiology and Metabolism, Department of Cardiology (CVK), Charité, Berlin, Germany.,Department of Cardiology (CBF), Charité, Berlin, Germany.,Berlin Institute of Health Center for Regenerative Therapies (BCRT), Berlin, Germany.,DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany
| | - Kalliopi Keramida
- Medical School, University of Cyprus, Nicosia, Cyprus.,Cardio-oncology clinic, Heart Failure Unit, Department of Cardiology, University Hospital Attikon, Athens, Greece
| | - Alessia Lena
- Division of Cardiology and Metabolism, Department of Cardiology (CVK), Charité, Berlin, Germany.,Department of Cardiology (CBF), Charité, Berlin, Germany.,Berlin Institute of Health Center for Regenerative Therapies (BCRT), Berlin, Germany.,DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany
| | - Angela Massouh
- School of Nursing, American University of Beirut, Beirut, Lebanon
| | - Ivan Milinkovic
- Clinical Center of Serbia, Belgrade University Faculty of Medicine, Belgrade, Serbia
| | | | | | - Rui Plácido
- Cardiology Department, Santa Maria University Hospital (CHLN), Lisbon Academic Medical Centre, and Centro Cardiovascular da Universidade de Lisboa, Faculdade de Medicina, Lisbon, Portugal
| | - Tamás Radovits
- Heart and Vascular Center, Semmelweis University, Budapest, Hungary
| | - Heli Tolppanen
- Heart and Lung Center, Division of Cardiology, Helsinki University and Helsinki University Hospital, Helsinki, Finland
| | - Giuseppe Vergaro
- Division of Cardiology and Cardiovascular Medicine, Fondazione Toscana Gabriele Monasterio, Pisa, Italy & Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy
| | - Markus Wallner
- Lewis Katz School of Medicine, Temple University, Cardiovascular Research Center, Philadelphia, PA, USA.,Division of Cardiology, Medical University of Graz, Graz, Austria.,Center for Biomarker Research in Medicine, CBmed GmbH, Graz, Austria
| | - Sophie Welch
- National Heart and Lung Institute, Imperial College London, London, UK
| | - Yuri Lopatin
- Volgograd Regional Cardiology Centre, Volgograd State Medical University, Volgograd, Russia
| | - Mitja Lainscak
- Faculty of Medicine, University of Ljubljana and Department of Internal Medicine, General Hospital Murska Sobota, Slovenia
| | - Alexandre Mebazaa
- Department of Anesthesiology and Critical Care Medicine, AP-HP, Saint Louis Lariboisière University Hospitals, Université de Paris, Paris, France
| | | | - Petar M Seferović
- Faculty of Medicine, University of Belgrade, Belgrade, Serbia.,Serbian Academy of Sciences and Arts, Belgrade, Serbia
| | - Ewa A Jankowska
- Centre for Heart Diseases, University Hospital, Wroclaw, and Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland
| | | |
Collapse
|
3
|
Adams L, Noutsias M, Bigalke B, Makowski MR. Magnetic resonance imaging in heart failure, including coronary imaging: numbers, facts, and challenges. ESC Heart Fail 2017; 5:3-8. [PMID: 29160621 PMCID: PMC5793958 DOI: 10.1002/ehf2.12236] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2017] [Accepted: 10/11/2017] [Indexed: 12/14/2022] Open
Abstract
Coronary artery disease (CAD) is a major risk factor for the incidence and progression of heart failure (HF). HF is characterized by a substantial morbidity and mortality and its lifetime risk is estimated at approximately 20% for men and women. As patients are in most cases identified only after developing overt clinical symptoms, detecting early stages of CAD and HF is of paramount importance. Due to its non‐invasiveness, excellent soft‐tissue contrast, high spatial resolution, and multiparametric nature, cardiovascular magnetic resonance (CMR) imaging has emerged as a promising radiation‐free technique to assess a wide range of cardiovascular diseases such as CAD or HF, enabling a comprehensive evaluation of myocardial anatomy, regional and global function, and viability with the additional benefit of in vivo tissue characterization. CMR has the potential to enhance our understanding of coronary atherosclerosis and the aetiology of HF on functional and biological levels, to identify patients at risk for CAD or HF, and to enable individualized patient management and improved outcomes. Even though larger‐scale studies on the different applications of CMR for the assessment of heart failure are scarce, recent research highlighted new possible clinical applications for CMR in the evaluation of CAD and HF.
Collapse
Affiliation(s)
- Lisa Adams
- Klinik für Radiologie, Charité - Universitätsmedizin Berlin, Campus Mitte, Charitéplatz 1, D -10117, Berlin, Germany
| | - Michel Noutsias
- Department of Internal Medicine I, Division of Cardiology, Pneumology, Angiology and Intensive Medical Care, University Hospital Jena, Friedrich Schiller University Jena, Jena, Germany
| | - Boris Bigalke
- Klinik für Kardiologie, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany
| | - Marcus R Makowski
- Klinik für Radiologie, Charité - Universitätsmedizin Berlin, Campus Mitte, Charitéplatz 1, D -10117, Berlin, Germany.,Division of Imaging Sciences and Biomedical Engineering, King's College London, London, UK
| |
Collapse
|